Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2510]

ESTRO: New test developed to detect men at high risk of prostate cancer recurrence

ESTRO: New test developed to detect men at high risk of prostate cancer recurrence

Certain genetic variants may put bladder cancer patients at increased risk of cancer recurrence

Certain genetic variants may put bladder cancer patients at increased risk of cancer recurrence

New UK approach to prostate cancer screening needed

New UK approach to prostate cancer screening needed

More intensive radiotherapy is better than less for localised prostate cancer

More intensive radiotherapy is better than less for localised prostate cancer

Genetic screening can identify men with advanced prostate cancer

Genetic screening can identify men with advanced prostate cancer

Study reveals potential route to bladder cancer diagnostics, treatments

Study reveals potential route to bladder cancer diagnostics, treatments

Proton therapy for prostate cancer results in long-term patient survival and excellent quality of life

Proton therapy for prostate cancer results in long-term patient survival and excellent quality of life

Reduction in cardiac events for prostate cancer patients with pre-existing cardiovascular disease with degarelix compared to LHRH agonists

Reduction in cardiac events for prostate cancer patients with pre-existing cardiovascular disease with degarelix...

Molecular characterisation of urothelial bladder carcinoma

Molecular characterisation of urothelial bladder carcinoma

ASCO GU: Common drug improves survival in hypertensive patients with metastatic renal cell carcinoma

ASCO GU: Common drug improves survival in hypertensive patients with metastatic renal cell carcinoma

More from ecancer